Be part of the knowledge - Global Oncology Academy

Medical News

wsj.com
12/02/2021
Medical News
COVID-19 Vaccines or Infections: Which Carries the Stronger Immunity?
Read more
eurekalert.org
12/02/2021
Medical News
Refinement of Genetic Signals for Psoriasis by Combining European-Origin & So...
Read more
dotmed.com
12/02/2021
Medical News
AI Breaks New Ground in Radiology Value-Based Care Delivery
Read more
businesswire.com
12/02/2021
Medical News
Carestream Demonstrates Leadership in Diagnostic Imaging at World’s Largest R...
Read more

See more news

- Paul Paik, MD
  Peer
- Viola Zhu, MD
  Peer
2
CME/CE
治疗差距：识别 NSCLC 管理中的新目标
治疗差距：识别 NSCLC 管理中的新目标
0.25 credits
治疗差距：识别 NSCLC 管理中的新目标
0.25 credits
- Nabil F. Saba, MD
  Peer
0
Project Oncology®
Head & Neck Cancer Updates from ESMO 2021
Head & Neck Cancer Updates from ESMO 2021
Head & Neck Cancer Updates from ESMO 2021
- Johann de Bono, MD, PhD
  Peer
- Alicia K. Morgans, MD, MPH
  Peer
0
CME/CE
Mantenerse al día con el cáncer genitourinario: Consideraciones clínicas para el cáncer de próstata: perspectivas globales
Mantenerse al día con el cáncer genitourinario: Consideraciones clínicas para el cáncer de próstata: perspectivas globales
0.25 credits
Mantenerse al día con el cáncer genitourinario: Consideraciones clínicas para...
0.25 credits
- Scott Kopetz, MD, PhD
  Peer
- Rona Yaeger, MD
  Peer
0
CME/CE
Evolving Management Strategies for BRAF-Mutant Metastatic Colorectal Cancer
Evolving Management Strategies for BRAF-Mutant Metastatic Colorectal Cancer
1.00 credits
Evolving Management Strategies for BRAF-Mutant Metastatic Colorectal Cancer
1.00 credits
- Jay Raman, MD, FACS
  Peer
- Oguz Akin, MD
  Peer
- Robert J. Motzer, MD
  Peer
- Elizabeth Plimack, MD, MS
  Peer
0
CME/CE
RCC Treatment Strategies in a Favorable-Risk Patient
RCC Treatment Strategies in a Favorable-Risk Patient
0.50 credits
RCC Treatment Strategies in a Favorable-Risk Patient
0.50 credits
- Jay Raman, MD, FACS
  Peer
- Oguz Akin, MD
  Peer
- Robert J. Motzer, MD
  Peer
- Elizabeth Plimack, MD, MS
  Peer
1
CME/CE
RCC Treatment Strategies in a Poor-Risk Patient
RCC Treatment Strategies in a Poor-Risk Patient
0.50 credits
RCC Treatment Strategies in a Poor-Risk Patient
0.50 credits
- Jennifer Caudle, DO
  Peer
- Brent A. Hanks, MD, PhD
  Peer
0
Medical Industry Feature
BRAF Mutations and the Role of Targeted Therapy in Patients With Stage III or IV Melanoma
BRAF Mutations and the Role of Targeted Therapy in Patients With Stage III or IV Melanoma
BRAF Mutations and the Role of Targeted Therapy in Patients With Stage III or...
- Kristi K. Orbaugh, MSN, NP, AOCN®
  Peer
- Val R. Adams, PharmD, FCCP, BCOP, FHOPA
  Peer
- Theresa W. Gillespie, PhD, MA, RN, FAAN
  Peer
0
CME/CE
Advanced Practice Perspectives on CDK 4/6 Inhibitors: Paving the Way for HR+, HER2-Negative Early Breast Cancer
Advanced Practice Perspectives on CDK 4/6 Inhibitors: Paving the Way for HR+, HER2-Negative Early Breast Cancer
1.00 credits
Advanced Practice Perspectives on CDK 4/6 Inhibitors: Paving the Way for HR+,...
1.00 credits

CME/CE

- Jeffrey S. Weber, MD, PhD
  Peer
0
CME/CE
Optimizing Treatment Selection and Side Effect Management in BRAF-Mutant Melanoma
Optimizing Treatment Selection and Side Effect Management in BRAF-Mutant Melanoma
1.00 credits
Optimizing Treatment Selection and Side Effect Management in BRAF-Mutant Mela...
1.00 credits
- Johann de Bono, MD, PhD
  Peer
- Alicia K. Morgans, MD, MPH
  Peer
0
CME/CE
Keeping Pace in GU Cancers: Clinical Considerations for Prostate Cancer – Global Perspectives
Keeping Pace in GU Cancers: Clinical Considerations for Prostate Cancer – Global Perspectives
0.25 credits
Keeping Pace in GU Cancers: Clinical Considerations for Prostate Cancer – Glo...
0.25 credits
- Maria E. Arcila, MD
  Peer
- Alexander Drilon, MD
  Peer
0
CME/CE
Practicing Precision in ALK and ROS1 Rearrangement Positive NSCLC: Testing, Targets, and Treatments
Practicing Precision in ALK and ROS1 Rearrangement Positive NSCLC: Testing, Targets, and Treatments
1.00 credits
Practicing Precision in ALK and ROS1 Rearrangement Positive NSCLC: Testing, T...
1.00 credits
- Paul Paik, MD
  Peer
- Joshua K. Sabari, MD
  Peer
5
CME/CE
Meeting Future Global Challenges: Case-Based Presentations in the Management of NSCLC
Meeting Future Global Challenges: Case-Based Presentations in the Management of NSCLC
0.25 credits
Meeting Future Global Challenges: Case-Based Presentations in the Management ...
0.25 credits

Clinical Practice

- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Dustin Sulak, DO
  Peer
5
Clinician's Roundtable
The Role of Cannabis in Medicine: Canceling Chronic Pain & Combating the Opioid Crisis
The Role of Cannabis in Medicine: Canceling Chronic Pain & Combating the Opioid Crisis
The Role of Cannabis in Medicine: Canceling Chronic Pain & Combating the ...
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Lincoln Nadauld, MD, PhD
  Peer
1
Project Oncology®
Advancements in Cancer Screening Technology: Multicancer Early Detection
Advancements in Cancer Screening Technology: Multicancer Early Detection
Advancements in Cancer Screening Technology: Multicancer Early Detection
- Hector O. Chapa, MD, FACOG
  Peer
- Julio M. Jimenez
  Peer
4
Clinician's Roundtable
Epigenetics in the Environment: An Exploration of Genetics & Chronic Health Conditions
Epigenetics in the Environment: An Exploration of Genetics & Chronic Health Conditions
Epigenetics in the Environment: An Exploration of Genetics & Chronic Heal...
1
Project Oncology®
How Structural Racism Impacts Cancer Disparities: Takeaways from ASCO 2021
How Structural Racism Impacts Cancer Disparities: Takeaways from ASCO 2021
How Structural Racism Impacts Cancer Disparities: Takeaways from ASCO 2021

Programs

- Paul Paik, MD
  Peer
- Joshua K. Sabari, MD
  Peer
5
CME/CE
迎接未来的全球挑战：NSCLC 控制中的病例介绍
迎接未来的全球挑战：NSCLC 控制中的病例介绍
0.25 credits
迎接未来的全球挑战：NSCLC 控制中的病例介绍
0.25 credits
- Paul Paik, MD
  Peer
- Jyoti D. Patel, MD, FASCO
  Peer
6
CME/CE
液体和组织活检在 NSCLC 治疗中的应用：关注 MET 基因畸变
液体和组织活检在 NSCLC 治疗中的应用：关注 MET 基因畸变
0.25 credits
液体和组织活检在 NSCLC 治疗中的应用：关注 MET 基因畸变
0.25 credits
- David R. Gandara, MD
  Peer
0
Project Oncology®
Emerging Research on Non-Small Cell Lung Cancer from ASCO 2021
Emerging Research on Non-Small Cell Lung Cancer from ASCO 2021
Emerging Research on Non-Small Cell Lung Cancer from ASCO 2021
- D. Ross Camidge, MD, PhD
  Peer
3
CME/CE
Improving the Quality of Care for Patients Harboring ALK+ NSCLC
Improving the Quality of Care for Patients Harboring ALK+ NSCLC
0.50 credits
Improving the Quality of Care for Patients Harboring ALK+ NSCLC
0.50 credits

Medical News

Medical News

Medical News

Medical News

Medical News

Popular

CME/CE

Project Oncology®

CME/CE

CME/CE

CME/CE

CME/CE

Medical Industry Feature

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

Clinical Practice

Clinician's Roundtable

Project Oncology®

Clinician's Roundtable

Project Oncology®

Programs

CME/CE

CME/CE

Project Oncology®

CME/CE

NEED HELP?

Contact us

NEED HELP?

Contact us

Medical News

Medical News

Medical News

Medical News

Medical News

Popular

CME/CE

Project Oncology®

CME/CE

CME/CE

CME/CE

CME/CE

Medical Industry Feature

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

Clinical Practice

Clinician's Roundtable

Project Oncology®

Clinician's Roundtable

Project Oncology®

Programs

CME/CE

CME/CE

Project Oncology®

CME/CE

Title

Share on ReachMD

Get a Dose of Global Oncology Academy in Your Inbox and Practice Smarter Medicine

Welcome to the newGlobal Oncology Academy website.

Welcome to the new
Global Oncology Academy website.